Robbins Farley Has $3.74 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Robbins Farley grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 28,252 shares of the financial services provider’s stock after purchasing an additional 907 shares during the quarter. iShares Biotechnology ETF comprises about 1.8% of Robbins Farley’s investment portfolio, making the stock its 28th largest position. Robbins Farley owned 0.06% of iShares Biotechnology ETF worth $3,735,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in IBB. Huntington National Bank raised its position in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares during the last quarter. National Bank of Canada FI increased its stake in shares of iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after buying an additional 229 shares during the period. Avior Wealth Management LLC raised its position in shares of iShares Biotechnology ETF by 438.2% during the third quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after acquiring an additional 2,629 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the period. Finally, Main Management ETF Advisors LLC boosted its holdings in iShares Biotechnology ETF by 2.5% in the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after acquiring an additional 14,535 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $137.85 on Tuesday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The business has a 50-day moving average price of $136.33 and a two-hundred day moving average price of $141.50.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.